Connect with us

Corona

COVID-19 : So far over 120 vaccines have been proposed across the world

Published

4 years ago

on

Global pharmaceutical major Pfizer is conducting clinical trials in the US and Europe for the BNT162 vaccine programme to prevent Covid-19 in collaboration with German mRNA company BioNTech.

Bourla made the comments while participating at a virtual event organised by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) this week.

PHOTO-GOOGLE

“If things go well and the stars are aligned, we will have enough evidence of safety and efficacy for us to feel comfortable, for the FDA (US Food and Drug Administration) to feel comfortable, and for the EMA (European Medicines Agency) to feel comfortable, to have a vaccine around the end of October,” Bourla was quoted as saying at the event by FierceBiotech.

PHOTO-GOOGLE

Speakers at the event also included AstraZeneca CEO Pascal Soriot, GlaxoSmithKline chief Emma Walmsley, Johnson & Johnson Chief Scientific Officer Paul Stoffels.

Each of these companies are working with their partners to develop a vaccine to prevent the disease.

PHOTO-GOOGLE

While GSK has joined forces with Sanofi, AstraZeneca is backing the vaccine being developed at the University of Oxford.

J&J is collaborating with the U.S. Biomedical Advanced Research and Development Authority to develop its vaccine.

PHOTO – GOOGLE

So far over 120 vaccines have been proposed across the world. Currently, there are at least 10 candidate vaccines in clinical evaluation and 115 candidate vaccines in pre-clinical evaluation.

PHOTO-GOOGLE

According to the WHO, it is important to evaluate as many vaccines as possible as we cannot predict how many will turn out to be viable.

To increase the chances of success, it is critical to test all candidate vaccines until they fail, the WHO said.

PHOTO – GOOGLE

Pfizer and BioNTech”s development programme includes four vaccine candidates, each representing a different combination of mRNA format and target antigen.

Coffee may help reduce the risk of certain digestive disorders

Related Topics:
Continue Reading

Corona

Covid toll in Karnataka is a worrying sign for state government

Published

3 years ago

on

May 4, 2022

By

 

Even though Karnataka recorded the lowest number of Covid deaths in April since the virus struck first in 2020, the state is recording a rise in the positivity rate (1.50 per cent). Five people died from the Covid infections in April as per the statistics released by the state health department. In March, the positivity rate stood around 0.53 per cent. In the first week of April it came down to 0.38 per cent, second week registered 0.56 per cent, third week it rose to 0.79 per cent and by end of April the Covid positivity rate touched 1.19 per cent.

on an average 500 persons used to succumb everyday in the peak of Covid infection, as per the data. Health experts said that the mutated Coronavirus is losing its fierce characteristics as vaccination, better treatment facilities and awareness among the people have contributed to the lesser number of Covid deaths.

During the 4th and 6th of April two deaths were reported in Bengaluru, one in Gadag district on April 8, two deaths were reported from Belagavi and Vijayapura on April 30. The first Covid case was reported in the state in March 2020 and three Covid deaths were recorded in the month. In the following month 21 people became victims to the deadly virus, and May 2020 recorded 22 deaths. The death toll recorded everyday after May crossed three digits. However, the third wave, which started in January 2

Continue Reading

Trending